Julia Lainster

The synchronization of patient consultations with inventory data ensures that every medication dispensed is immediately reflected in a facility’s stock records. This technological shift represents a fundamental departure from the era of handwritten ledgers and manual tallying that previously

Managing the spread of cancer to the vertebral column remains one of the most significant clinical hurdles for oncologists today, as the risk of neurological damage often limits the ability to perform invasive diagnostic procedures. Significant differences in protein concentration and pH levels

Physicians are strictly prohibited from sharing or delegating their digital access tokens to maintain the security of remote medical record authentication. As healthcare continues its rapid transformation toward a fully digital ecosystem, the National Medical Commission (NMC) has stepped in to

The collaboration between Quanterix and Innovita leverages localized manufacturing and regulatory expertise to bring advanced diagnostic kits to the Chinese healthcare market. This initiative emerges as a critical response to the mounting pressure on the region's medical infrastructure, which

Effective breast cancer management now relies on imaging to track the patient's response to therapy and adjust treatment plans in real time. This dynamic approach marks a significant departure from the static, population-based screening models that dominated the medical landscape for decades. As

The FDA’s Total Product Lifecycle approach mandates that cybersecurity considerations begin at the initial design phase and continue until the device is decommissioned. This paradigm shift reflects the reality of 2026, where medical technology is no longer comprised of standalone hardware but

Success in treating recurrent prostate cancer hinges on the ability to detect disease at extremely low PSA values where traditional imaging often fails. For years, clinicians struggled with blind spots during biochemical recurrence, where rising PSA levels indicated the presence of cancer, yet

The ongoing evolution of the medical sector has recently reached a pivotal crossroads where the heavy burden of administrative tasks is finally being met by high-performance artificial intelligence. Suki’s recent procurement of a $90 million Series E funding round signifies a transformative moment

Ingenio Medical Group intends to function as the connective tissue between disparate healthcare settings, such as virtual clinics, local specialists, and diagnostic laboratories. This initiative emerges at a time when the American healthcare system remains deeply fragmented, often leaving patients

This collaboration focuses on translating high-value cellular insights into sensitive clinical assays that remain consistent across diverse geographic regions and laboratory settings. By establishing this strategic alliance, CellCarta and Waters Corporation create a robust pathway for biotechnology